PD-L1 blockade enhances anti-tumor efficacy of NK cells.

There were also virtually no Tregs in the ip cavity of mice treated with anti-PD-L1 although Tregs were also low in the NK only treated group for this donor and the difference did not reach statistical significance ( Figure 4F ).

also in 111,027 other papers